| [1] |
Sia D, Villanueva A, Friedman SL, et al. Liver cancer cell of origin, molecular class, and effects on patient prognosis[J]. Gastroenterology, 2017, 152(4):745-761.
|
| [2] |
Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2016(2):16018.
|
| [3] |
Su CH, Lin Y, Cai L. Genetic factors, viral infection, other factors and liver cancer: an update on current progress[J]. Asian Pac J Cancer Prev, 2013, 14(9):4953-4960.
|
| [4] |
Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury[J]. Nat Chem Biol, 2005, 1(2):112-119.
|
| [5] |
Seehawer M, Heinzmann F, D'Artista L, et al. Necroptosis microenvironment directs lineage commitment in liver cancer[J]. Nature, 2018, 562(7725):69-75.
|
| [6] |
Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis: an ordered cellular explosion[J]. Nat Rev Mol Cell Biol, 2010, 11(10):700-714.
|
| [7] |
Najafov A, Chen H, Yuan J. Necroptosis and Cancer[J]. Trends Cancer, 2017, 3(4):294-301.
|
| [8] |
Vanlangenakker N, Vanden Berghe T, Bogaert P, et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production[J]. Cell Death Differ, 2011, 18(4): 656-665.
|
| [9] |
Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(12):738-752.
|
| [10] |
Wang L, Du F, Wang X. TNF-alpha induces two distinct caspase-8 activation pathways[J]. Cell, 2008, 133(4):693-703.
|
| [11] |
Dondelinger Y, Jouan-Lanhouet S, Divert T, et al. NF-kappaB-independent role of IKKalpha/IKKbeta in preventing RIPK1 kinase-dependent apoptotic and necroptotic cell death during TNF signaling[J]. Mol Cell, 2015, 60(1):63-76.
|
| [12] |
Vanden Berghe T, Vanlangenakker N, Parthoens E, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features[J]. Cell Death Differ, 2010, 17(6): 922-930.
|
| [13] |
Han J, Zhong CQ, Zhang DW. Programmed necrosis: backup to and competitor with apoptosis in the immune system[J]. Nat Immunol, 2011, 12(12):1143-1149.
|
| [14] |
Simenc J, Lipnik-Stangelj M. Staurosporine induces different cell death forms in cultured rat astrocytes[J]. Radiol Oncol, 2012, 46(4): 312-320.
|
| [15] |
Chen X, Li W, Ren J, et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death[J]. Cell Res, 2014, 24(1):105-121.
|
| [16] |
Murphy JM, Czabotar PE, Hildebrand JM, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism[J]. Immunity, 2013, 39(3):443-453.
|
| [17] |
Wang Z, Jiang H, Chen S, et al. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways[J]. Cell, 2012, 148(1/2):228-243.
|
| [18] |
Ofengeim D, Yuan J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death[J]. Nat Rev Mol Cell Biol, 2013, 14(11):727-736.
|
| [19] |
Moriwaki K, Bertin J, Gough PJ, et al. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death[J]. Cell Death Dis, 2015, 6(2):e1636.
|
| [20] |
Liu P, Xu B, Shen W, et al. Dysregulation of TNFalpha-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1[J]. Leukemia, 2012, 26(6):1293-1300.
|
| [21] |
Bhattacharya S, Chalk AM, Ng AJM, et al. Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death[J]. Oncogene, 2016, 35(40):5282-5294.
|
| [22] |
Colbert LE, Fisher SB, Hardy CW, et al. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma[J]. Cancer, 2013, 119(17):3148-3155.
|
| [23] |
He L, Peng K, Liu Y, et al. Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients[J]. Onco Targets Ther, 2013(6):1539-1543.
|
| [24] |
Li X, Guo J, Ding AP, et al. Association of mixed lineage kinase domain-like protein expression with prognosis in patients with colon cancer[J]. Technol Cancer Res Treat, 2017, 16(4):428-434.
|
| [25] |
Fu Z, Deng B, Liao Y, et al. The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis[J]. BMC Cancer, 2013(13):580.
|
| [26] |
Philipp S, Sosna J, Adam D. Cancer and necroptosis: friend or foe?[J]. Cell Mol Life Sci, 2016, 73(11/12):2183-2193.
|
| [27] |
Yatim N, Jusforgues-Saklani H, Orozco S, et al. RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells[J]. Science, 2015, 350(6258):328-334.
|
| [28] |
Seifert L, Werba G, Tiwari S, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression[J]. Nature, 2016, 532(7598):245-249.
|
| [29] |
Strilic B, Yang L, Albarrán-Juárez J, et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis[J]. Nature, 2016, 536(7615):215-218.
|
| [30] |
Wu Y, Zhou BP. Inflammation: a driving force speeds cancer metastasis[J]. Cell Cycle, 2014, 8(20):3267-3273.
|
| [31] |
Liu ZY, Wu B, Guo YS, et al. Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice[J]. Am J Cancer Res, 2015, 5(10):3174-3185.
|
| [32] |
Liu XY, Lai F, Yan XG, et al. RIP1 kinase is an oncogenic driver in melanoma[J]. Cancer Res, 2015, 75(8):1736-1748.
|